Product NDC: | 60977-116 |
Proprietary Name: | Ativan |
Non Proprietary Name: | lorazepam |
Active Ingredient(s): | 2 mg/mL & nbsp; lorazepam |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60977-116 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018140 |
Marketing Category: | NDA |
Start Marketing Date: | 20090924 |
Package NDC: | 60977-116-02 |
Package Description: | 10 VIAL in 1 PACKAGE (60977-116-02) > 10 mL in 1 VIAL (60977-116-01) |
NDC Code | 60977-116-02 |
Proprietary Name | Ativan |
Package Description | 10 VIAL in 1 PACKAGE (60977-116-02) > 10 mL in 1 VIAL (60977-116-01) |
Product NDC | 60977-116 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | lorazepam |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20090924 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | LORAZEPAM |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |